NCT02167204View on ClinicalTrials.gov

18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 21, 2019

Study Completion Date

January 21, 2019

Conditions
Metastatic Malignant Neoplasm in the BrainPrimary Brain NeoplasmRecurrent Brain Neoplasm
Interventions
PROCEDURE

Computed Tomography

Undergo 18F-FLT PET/CT

RADIATION

Fluorothymidine F-18

Undergo 18F-FLT PET/CT

PROCEDURE

Positron Emission Tomography

Undergo 18F-FLT PET/CT

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT02167204 - 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors | Biotech Hunter | Biotech Hunter